APPEND-CT Registry
Launched by AARHUS UNIVERSITY HOSPITAL · Jan 9, 2024
Trial Information
Current as of July 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
An investigator-driven multicenter retrospective observational database enrolling patients from high-volume North American and European centers. The database will include Watchman FLX implanted patients with a minimum of one follow-up cardiac CT performed within 45-120 days post-procedure. Additional timepoints may be entered. Cardiac CT scans are to be uploaded and will be analyzed by the core-lab at Aarhus University Hospital.
Investigator-reported findings will be systematically reported to the database. This includes information on baseline characteristics, preprocedural planning, impl...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Watchman FLX LAAO
- • A minimum of one follow-up cardiac CT performed within 30-120 days post-procedure.
- • A minimum of one year clinical follow-up data
About Aarhus University Hospital
Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Rochester, Minnesota, United States
Aarhus, , Denmark
Patients applied
Trial Officials
Anders Kramer, MD
Principal Investigator
Aarhus University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported